Nutrition and Metabolism Research Program, Child and Family Research Institute, Department of Paediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
PLoS One. 2012;7(8):e43448. doi: 10.1371/journal.pone.0043448. Epub 2012 Aug 20.
The importance of maternal dietary choline for fetal neural development and later cognitive function has been well-documented in experimental studies. Although choline is an essential dietary nutrient for humans, evidence that low maternal choline in pregnancy impacts neurodevelopment in human infants is lacking. We determined potential associations between maternal plasma free choline and its metabolites betaine and dimethylglycine in pregnancy and infant neurodevelopment at 18 months of age.
This was a prospective study of healthy pregnant women and their full-term, single birth infants. Maternal blood was collected at 16 and 36 weeks of gestation and infant neurodevelopment was assessed at 18 months of age for 154 mother-infant pairs. Maternal plasma choline, betaine, dimethylglycine, methionine, homocysteine, cysteine, total B12, holotranscobalamin and folate were quantified. Infant neurodevelopment was evaluated using the Bayley Scales of Infant Development-III. Multivariate regression, adjusting for covariates that impact development, was used to determine the associations between maternal plasma choline, betaine and dimethylglycine and infant neurodevelopment.
The maternal plasma free choline at 16 and 36 weeks gestation was median (interquartile range) 6.70 (5.78-8.03) and 9.40 (8.10-11.3) µmol/L, respectively. Estimated choline intakes were (mean ± SD) 383 ± 98.6 mg/day, and lower than the recommended 450 mg/day. Betaine intakes were 142 ± 70.2 mg/day. Significant positive associations were found between infant cognitive test scores and maternal plasma free choline (B=6.054, SE=2.283, p=0.009) and betaine (B=7.350, SE=1.933, p=0.0002) at 16 weeks of gestation. Maternal folate, total B12, or holotranscobalamin were not related to infant development.
We show that choline status in the first half of pregnancy is associated with cognitive development among healthy term gestation infants. More work is needed on the potential limitation of choline or betaine in the diets of pregnant women.
母体膳食胆碱对胎儿神经发育和后期认知功能的重要性在实验研究中得到了充分证明。尽管胆碱是人类必需的膳食营养素,但缺乏证据表明妊娠期间母体胆碱水平低会影响人类婴儿的神经发育。我们确定了妊娠期间母体血浆游离胆碱及其代谢物甜菜碱和二甲氨基乙醇与 18 个月龄婴儿神经发育之间的潜在关联。
这是一项针对健康孕妇及其足月单胎婴儿的前瞻性研究。在 16 周和 36 周妊娠时采集母体血液,并对 154 对母婴进行 18 个月的婴儿神经发育评估。定量检测母体血浆胆碱、甜菜碱、二甲氨基乙醇、蛋氨酸、同型半胱氨酸、半胱氨酸、总 B12、全钴胺素和叶酸。使用贝利婴幼儿发育量表-III 评估婴儿神经发育。采用多元回归,调整影响发育的协变量,确定母体血浆游离胆碱、甜菜碱和二甲氨基乙醇与婴儿神经发育之间的关系。
妊娠 16 周和 36 周时母体血浆游离胆碱中位数(四分位距)分别为 6.70(5.78-8.03)和 9.40(8.10-11.3)µmol/L。估计的胆碱摄入量(平均值±标准差)为 383±98.6mg/天,低于推荐的 450mg/天。甜菜碱摄入量为 142±70.2mg/天。在妊娠 16 周时,婴儿认知测试评分与母体血浆游离胆碱(B=6.054,SE=2.283,p=0.009)和甜菜碱(B=7.350,SE=1.933,p=0.0002)呈显著正相关。母体叶酸、总 B12 或全钴胺素与婴儿发育无关。
我们表明,妊娠前半段的胆碱状态与健康足月妊娠婴儿的认知发育有关。需要进一步研究孕妇饮食中胆碱或甜菜碱的潜在局限性。